Staining for the human lymphatic marker podoplanin and VCAM-1 revealed a robust expression of VCAM-1 in the lymphatics in end-stage COPD patients that was not present in control lymphatics (Figures 6A–D). This evidence concerns the gene VCAM1 and chronic obstructive pulmonary disease.